Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

42.71
Delayed Data
As of 4:02pm ET
 +0.70 / +1.67%
Today’s Change
36.71
Today|||52-Week Range
44.85
+7.36%
Year-to-Date
PhaseRX: The Latest Pick From a Legendary VC Firm
6:38pm / GuruFocus News - Paid Partner Content
Novartis (NVS) to Stop Trial on Breast Cancer Drug Early
May 18 / Zacks.com - Paid Partner Content
Pfizer Champix's Label to Include More Data, Warning Lifted
10:02am / Zacks.com - Paid Partner Content
AstraZeneca's Severe Asthma Drug Positive in Phase III
May 18 / Zacks.com - Paid Partner Content
3 Stocks With a Bigger Dividend Than Coca-Cola
9:38am / MotleyFool.com - Paid Partner Content
Inovio Pharmaceuticals' Zika Vaccine Takes a Big Step Forward
May 17 / MotleyFool.com - Paid Partner Content
The Best Buys in Biopharma Today
9:12am / MotleyFool.com - Paid Partner Content
Perrigo (PRGO) Tops Q1 Earnings, 2016 Earnings View Intact
May 12 / Zacks.com - Paid Partner Content
Glaxo/Innoviva Unveil SUMMIT Study Data on Breo Ellipta
May 19 / Zacks.com - Paid Partner Content